PRODUIT COMPRENANT AU MOINS UN ARN DOUBLE BRIN EN ASSOCIATION AVEC AU MOINS UN AGENT ANTI-VIRAL POUR UNE UTILISATION THERAPEUTIQUE DANS LE TRAITEMENT D'UNE MALADIE VIRALE, NOTAMMENT D'UNE HEPATITE VIRALE

摘要

Product (A) comprises (a) at least one double-stranded RNA (I) and (b) at least one interferon (II) for treatment of viral hepatitis by administration simultaneously, separately or staged in time. An Independent claim is also included for a pharmaceutical composition containing (A) plus excipients and carriers.